$XXX X% million, Thank quarter We the sales of quarter the fourth from up XXXX. fourth finished of with you, Ashish.
$XXX X% million, the sales from For down XXXX. year, were full
up markets and sales XX%, the and period quarter, diversified sales to aerospace XX% medical, from end including the industrial were For down sales, were defense same while year. end market last transportation
diversified up market for market acquisition, revenue XXXX. XXXX. full XX% to SyQwest of were Diversified sales quarter the the fourth quarter XX% fourth the the the were and compared company Excluding overall sales end year for in fourth quarter end in X%
book-to-bill fourth remained the fourth of X.XX, Our similar at ratio the for quarter to quarter XXXX.
XXXX, share We fourth For for in the achieved XXXX. ratio probability year-over-year. full the of XXX the gross up diluted versus Fourth in year adjusted basis XXX were margin the X.XX and solid $X.XX up points per quarter X.XX improvements full earnings book-to-bill points with XX% basis was in quarter year.
For the full year earnings XXXX, XXXX. per down share $X.XX, in $X.XX adjusted diluted were from
further financial will later on in Ashish performance our add call. today's color
expectations, million the as line market, $XX sequentially in book-to-bill quarter XXXX. our medical of the the ratio fourth full $XX quarter adjusted customers X%. to year fourth were compared XXXX with down was up In to in XXXX, X.XX in fourth In X.XX inventory compared were sales their million sales The quarter levels.
make it the help invasive medications. which deliver professionals restrictions and for enhanced growth easier for applications We minimally prospects our are ultrasound artery products by excited medical deliver detect for to images, in treatment
We are products that lives. save support proud solutions that to help highlight our
order for a regions had application secured the wins therapeutics. During for medical and medical we across in quarter, ultrasound fourth large used all an
new volume we another in for growth enhance application. a and tumors win expect treatment of second Additionally, customers, our Over application. application, echocardiograph for for medical therapeutics for temperature a application a X a ultrasound had we diagnostics and growth laboratory portable time, an veterinary will one We customer added profile. ultrasound liver
defense sales full $XX $XX XX% therapeutic Aerospace strengthening million, and in seeing in year XXXX for products. XXXX. million up are we mentioned, already I the from were for As demand
the in up a healthy were sales year. maintain of prior Bookings acquisition, down we from year as SyQwest period, backlog. X% our from timing due were sales orders mainly for full to fourth Excluding quarter X% the the
from Our strategy moving is on of sensors, supplier and transducers a focused component to supplier subsystems. a
product of and range integration. market after expand We also period a opportunity expect to our
We in ] and solar the applications [ Europe. orders for in received multiple America quarter North
had in its applications to business temperature integration wins plan, funnel. also for is opportunity the sensing. a and We win for The and filters the RF of to business SyQwest continued anti-jamming tracking drive
gradual naval underscoring recovery During In of the article on we see expectation prior up recovery the work completed XX% the end market, as compared Sales sequentially first up we as quarter fourth industrial with in industrial gradual well the in period, year our platforms. and OEMs. to in X fourth quarter, distribution were X% the market. a a
with compared year Bookings For $XXX million XXXX. appear Inventory from quarter full the million period now in as well successful to last multiple more were for appliances, to printing, XXXX, switches, home sales for were up in EMC and and wins year. in were pool same spa $XXX distribution. We current be wins levels X% as normalized. for the temperature sensing the sensing applications, the industrial quarter industrial
quarter communications the quarter, customer down rebuild year. were approximately is new application. XXXX. prospects. Transportation last $XX the megatrends The and in in across XX% efficiency, fourth from the broadband to a the period for million expected automation, of enhance same added growth sales a longer-term market Demand our in We connectivity industrial
with accelerator Europe and wins We had for chassis module sensor exhaust across XXXX, product softness $XXX wins in wins In competition market. including XXXX, year in from commercial ride groups, position the down America. seat China, OEMs sales North we China million, transplant quarter, in million sensing, full for the and sensing. the fourth $XXX by vehicle height For and driven OEMs in primarily various had were demand sensing
new customer North During and platform in design modules. quarter, our for X added accelerator a fourth accelerator for we wins the modular America EV had
XXXX are us the products drivetrain EVs on mostly Total of earnings a premium our our ICE mentioned hybrids less near-term agnostic from was our concern for we expect the decisions, approximately received and end increased improve have OEM book to and the As sales The Recently, this for delay to America, technology. for continued of administration. get initiatives. policy eBrake EV business award we last at rates are in of $X.X European billion anticipation a predevelopment call, clarity changes subsidy a OEMs the product. likely as from government in more growth North versus have quarter. they on but new in to given sourcing
continues increase. and our expect our forward, with OEMs sales weight design to product eBrake where in Going we advantages team several cost is and samples hybrid proceeding offering customization. across Interest
applications content. to We ability will our expect and our other grow increase sensor eBrake
outlook XXXX. the to for Turning
with to high-quality to orders expected our technologies leading to our backlog growth. expand in end to quarter our line expect is growth range now may and For improve of remain customer in in term, year remainder defense, the demand and that and expected our first is aerospace inventory Industrial levels our solid our gradually aim strategy. Longer diversification volume and X primarily to the and given the distribution normalized. from diversified Demand strategy, end markets sales applications. have markets, momentum In in the supported base XXXX of driven medical are key the with market the formulations of we continue by therapeutic soft strengthen expected medical acquisition. of line the be ultrasound in in by drive to and SyQwest material we
are North XXXX. growing. light in million volumes range to Across transportation expected market days to in vehicle from American of units, supply expected the year with is production be XX on-hand down The markets, be mixed last of
overcapacity and down to rates reducing Some the build production regions, the penetration have burn some showing due improve. while in China volumes forecasted unit hybrid is pressure half unit in softness from some expected in OEMs range Chinese the to million to be adoption inventory million continues first OEMs. XX Electric increased range. softened European are production are vehicle rates in levels. XX.X to
due revenue headwinds factors. other we in dynamics China market and Overall, regional anticipate to the our transportation
We next-generation our second commercial actuator in the to expect quarter. go into production vehicle
However, vehicle commercial we XXXX. anticipate softness revenue throughout in
introduce our the of of The may the U.S. revenue seasonality be from timing influenced of by where SyQwest funding year acquisition approval government. will some full by first revenue
for be the the half XXXX. expect second stronger will We SyQwest revenues in of
of in EPS adjusted year full in $X.XX to $X.XX. $XXX we to sales million For be of the diluted range range and million XXXX, the to expect $XXX
Ashish, turn us walk I'll the detail. more the in over results who will financial through Now call to
Ashish?